Search details
1.
Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
Ann Surg Oncol
; 31(4): 2231-2243, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38158494
2.
Patient-Reported Outcomes in Patients Undergoing Lumpectomy With and Without Defect Closure.
Ann Surg Oncol
; 31(3): 1615-1622, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38063989
3.
Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction.
Ann Surg Oncol
; 31(2): 966-973, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37973646
4.
Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?
Breast Cancer Res Treat
; 197(2): 417-423, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36394689
5.
Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Breast Cancer Res Treat
; 198(2): 349-359, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36754936
6.
Axillary Staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden.
Ann Surg Oncol
; 30(1): 92-97, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-35876927
7.
The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q.
Ann Surg Oncol
; 30(9): 5341-5349, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37306849
8.
Timing of Chemotherapy and Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Immediate Reconstruction.
Ann Surg Oncol
; 30(5): 2897-2909, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36737530
9.
Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
Ann Surg Oncol
; 30(7): 4087-4094, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36905438
10.
Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
Ann Surg Oncol
; 30(10): 6061-6069, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37493892
11.
Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
Ann Surg Oncol
; 30(12): 6990-6999, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37661222
12.
Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 30(12): 7091-7098, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37556008
13.
Satisfaction and Well-Being After Contralateral Prophylactic Mastectomy Among BRCA Mutation Carriers and Noncarriers: A Longitudinal Analysis of BREAST-Q Domains.
Ann Surg Oncol
; 30(12): 7116-7123, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37581851
14.
Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer.
Ann Surg Oncol
; 30(13): 8412-8418, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37798552
15.
Patient-Reported Outcome Measures for Patients Who Have Clinical T4 Breast Cancer Treated via Mastectomy with and Without Reconstruction.
Ann Surg Oncol
; 30(1): 115-121, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36149609
16.
ASO Visual Abstract: Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy With and Without Reconstruction.
Ann Surg Oncol
; 30(1): 124-125, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36207484
17.
Strategies to avoid mastectomy skin-flap necrosis during nipple-sparing mastectomy.
Br J Surg
; 110(7): 831-838, 2023 06 12.
Article
in English
| MEDLINE | ID: mdl-37178195
18.
A Review of the Estimation of Sensitivity and Specificity in the Context of Time-Dependent Outcomes.
J Magn Reson Imaging
; 2023 Oct 18.
Article
in English
| MEDLINE | ID: mdl-37850689
19.
Multisite MRI Intravoxel Incoherent Motion Repeatability and Reproducibility across 3 T Scanners in a Breast Diffusion Phantom: A BReast Intravoxel Incoherent Motion Multisite (BRIMM) Study.
J Magn Reson Imaging
; 2023 Sep 13.
Article
in English
| MEDLINE | ID: mdl-37702382
20.
Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
Cancer
; 128(3): 471-478, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34597420